![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
National Center for Research Resources (NCRR) Children's Hospital Medical Center, Cincinnati |
---|---|
Information provided by: | National Center for Research Resources (NCRR) |
ClinicalTrials.gov Identifier: | NCT00005105 |
OBJECTIVES:
I. Determine if mutations in the gene encoding the insulin-like growth factor-I receptor lead to relative insulin-like growth factor-I insensitivity and produce intrauterine growth retardation in children.
Condition |
---|
Intrauterine Growth Retardation |
Study Type: | Observational |
Study Design: | Screening |
Estimated Enrollment: | 75 |
Study Start Date: | January 1997 |
PROTOCOL OUTLINE:
Patients undergo blood draw. Insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) are measured. Patients whose IGF-I and IGFBP-3 levels are average or above are tested for the presence of mutation in the insulin-like growth factor-I receptor.
Ages Eligible for Study: | 18 Months to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
United States, Georgia | |
Emory University School of Medicine | Terminated |
Atlanta, Georgia, United States, 30322 | |
United States, Indiana | |
James Whitcomb Riley Hospital for Children | Active, not recruiting |
Indianapolis, Indiana, United States, 46202-5225 | |
United States, New York | |
Schneider Children's Hospital | Recruiting |
New Hyde Park, New York, United States, 11042 | |
Contact: Graeme Frank 718-470-3390 | |
United States, Ohio | |
Children's Hospital Medical Center - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45229-3039 | |
Contact: Steven D. Chernausek 513-636-4744 | |
United States, Virginia | |
Medical College of Virginia School of Medicine | Recruiting |
Richmond, Virginia, United States, 23298-0230 | |
Contact: Paul Kaplowitz 804-786-9788 |
Study Chair: | Steven D. Chernausek | Children's Hospital Medical Center, Cincinnati |
Study ID Numbers: | 199/14924, CHMC-C-96-10-4 |
Study First Received: | April 6, 2000 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00005105 History of Changes |
Health Authority: | United States: Federal Government |
endocrine disorders intrauterine growth retardation rare disease |
Fetal Diseases Pregnancy Complications Growth Disorders Rare Diseases Mitogens |
Endocrine System Diseases Endocrinopathy Insulin Fetal Growth Retardation |
Fetal Diseases Pathologic Processes Pregnancy Complications Growth Disorders Fetal Growth Retardation |